Michael Lundquist Grant to Advance MSA-C Research
Annual grant supporting innovative research to advance understanding, diagnosis, and treatment of multiple system atrophy, cerebellar subtype (MSA-C).
Funder: National Ataxia Foundation
Due Dates (Anticipated): August 2026 (Letter of Intent) | December 2026 (Full application)
Funding Amounts: Up to $50,000 for a one-year project; direct research expenses only; no indirect costs allowed.
Summary: Annual grant supporting innovative research to advance understanding, diagnosis, and treatment of multiple system atrophy, cerebellar subtype (MSA-C).
Description
This annual grant from the National Ataxia Foundation supports independent researchers conducting preclinical, translational, or clinical research focused on multiple system atrophy, cerebellar subtype (MSA-C). The program prioritizes projects that accelerate disease-modifying therapy development, enable clinical trial readiness (including biomarker discovery and validation), improve diagnostic methods, bridge scientific discovery and therapeutic application, and advance mechanistic understanding of MSA-C pathogenesis. The grant is designed to drive meaningful progress in the treatment and care of individuals affected by MSA-C, honoring Michael Lundquist’s legacy and the Foundation’s mission to improve outcomes for those living with ataxia.
